FDA inspection
Rubicon Research Private Ltd: FDA inspection ending Jun 20, 2023
FDA inspection 1208386 · Official Action Indicated (OAI) · Thane
Key facts
| Inspection ID | 1208386 |
|---|---|
| Firm | Rubicon Research Private Ltd |
| FEI number | 3006559899 |
| Address | Medone House B - 75, Road No 33 |
| City | Thane |
| Fiscal year | 2023 |
| Inspection end date | Jun 20, 2023 |
| Classification | Official Action Indicated (OAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data